|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
|
US5714465A
(en)
|
1989-05-19 |
1998-02-03 |
Amgen Inc. |
Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor
|
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
|
US5574138A
(en)
|
1993-03-08 |
1996-11-12 |
Immunex Corporation |
Epithelium-derived T-cell factor
|
|
US7138500B1
(en)
|
1993-05-07 |
2006-11-21 |
Immunex Corporation |
Antibodies to human 4-1BB
|
|
US7211259B1
(en)
|
1993-05-07 |
2007-05-01 |
Immunex Corporation |
4-1BB polypeptides and DNA encoding 4-1BB polypeptides
|
|
US7045128B2
(en)
|
1993-05-24 |
2006-05-16 |
Immunex Corporation |
Antibodies against flt3-ligand
|
|
US6630143B1
(en)
|
1993-05-24 |
2003-10-07 |
Immunex Corporation |
Antibodies against flt3 ligand
|
|
US6303769B1
(en)
|
1994-07-08 |
2001-10-16 |
Immunex Corporation |
Lerk-5 dna
|
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
|
US5919905A
(en)
|
1994-10-05 |
1999-07-06 |
Immunex Corporation |
Cytokine designated LERK-6
|
|
US6406901B1
(en)
|
1995-06-08 |
2002-06-18 |
Immunex Corporation |
TNF-a converting enzyme
|
|
ZA976326B
(en)
|
1996-07-19 |
1998-02-03 |
Amgen Inc |
Analogs of cationic proteins.
|
|
ES2144386T5
(es)
|
1996-12-23 |
2012-12-07 |
Immunex Corporation |
Ligando para el activador del receptor de NF-kappa b, el ligando es miembro de la superfamilia de TNF
|
|
US5741772A
(en)
|
1997-02-03 |
1998-04-21 |
Amgen Inc. |
Neurotrophic factor NNT-1
|
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
|
NZ500253A
(en)
|
1997-04-16 |
2002-09-27 |
Amgen Inc |
Osteoprotegerin binding proteins and receptors
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
US20020173629A1
(en)
|
1997-05-05 |
2002-11-21 |
Aya Jakobovits |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
CA2315251A1
(en)
|
1997-12-17 |
1999-06-24 |
Immunex Corporation |
Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
|
|
AU755391B2
(en)
|
1997-12-23 |
2002-12-12 |
Immunex Corporation |
SIGIRR DNA and polypeptides
|
|
WO1999033878A1
(en)
|
1997-12-25 |
1999-07-08 |
Japan Tobacco Inc. |
Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
|
|
EP1049777B1
(en)
|
1998-01-23 |
2005-08-03 |
Immunex Corporation |
Acpl dna and polypeptides
|
|
NZ510357A
(en)
|
1998-08-07 |
2004-02-27 |
Immunex Corp |
Molecules designated B7L-1
|
|
DE69942861D1
(de)
|
1998-08-07 |
2010-11-25 |
Immunex Corp |
Ldcam genannte moleküle
|
|
JP4454859B2
(ja)
|
1998-11-13 |
2010-04-21 |
イミュネックス・コーポレーション |
ヒトtslpdnaおよびポリペプチド
|
|
US7109003B2
(en)
|
1998-12-23 |
2006-09-19 |
Abgenix, Inc. |
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
|
|
EE05627B1
(et)
|
1998-12-23 |
2013-02-15 |
Pfizer Inc. |
CTLA-4 vastased inimese monoklonaalsed antikehad
|
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
|
EP2270150B2
(en)
|
1999-04-09 |
2019-08-07 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
|
JP2001206899A
(ja)
|
1999-11-18 |
2001-07-31 |
Japan Tobacco Inc |
TGF−βII型受容体に対するヒトモノクローナル抗体及びその医薬用途
|
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
|
AU2001272925A1
(en)
|
2000-05-26 |
2001-12-11 |
Immunex Corporation |
Use of interleukin-4 antagonists and compositions thereof
|
|
WO2002020762A2
(en)
|
2000-09-05 |
2002-03-14 |
Amgen Inc. |
Tnf receptor-like molecules and uses thereof
|
|
MX349009B
(es)
|
2001-01-05 |
2017-07-06 |
Pfizer |
Anticuerpos contra el receptor del factor de crecimiento similar a insulina.
|
|
US6887687B2
(en)
|
2001-07-30 |
2005-05-03 |
Immunex Corporation |
Nucleic acids encoding human ataxin-1-like polypeptide IMX97018
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
US7658924B2
(en)
|
2001-10-11 |
2010-02-09 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
EP1448588A4
(en)
|
2001-10-23 |
2006-10-25 |
Psma Dev Company L L C |
ANTIBODIES AND MULTIMERS OF PSMA PROTEINS
|
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
CA2467738A1
(en)
|
2001-12-03 |
2003-06-12 |
Abgenix, Inc. |
Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
|
|
AU2002351204B2
(en)
|
2001-12-03 |
2008-07-10 |
Abgenix, Inc. |
Anti-CD45RB antibodies for use in treating autoimmune disease and transplant rejection
|
|
DE60220719T2
(de)
|
2001-12-28 |
2008-03-06 |
Amgen Fremont Inc. |
Antikörper gegen das muc18-antigen
|
|
EP1467756A4
(en)
|
2001-12-28 |
2007-03-21 |
Abgenix Inc |
METHODS OF USING ANTI-MUC18 ANTIBODIES
|
|
EP1467757B1
(en)
|
2001-12-28 |
2008-05-07 |
Amgen Fremont Inc. |
Use of antibodies against the muc18 antigen
|
|
US7135174B2
(en)
|
2002-01-07 |
2006-11-14 |
Amgen Fremont, Inc. |
Antibodies directed to PDGFD and uses thereof
|
|
ES2327830T3
(es)
|
2002-03-29 |
2009-11-04 |
Schering Corporation |
Anticuerpos monoclonales humanos anti-interleuquina-5 y metodos y composiciones que los contienen.
|
|
CA2481074A1
(en)
|
2002-04-05 |
2003-10-23 |
Amgen Inc. |
Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
|
|
UA87979C2
(ru)
|
2002-08-19 |
2009-09-10 |
Астразенека Аб |
Человеческое моноклональное антитело, которое нейтрализует моноцитарный хемоатрактантный белок (мср-1)
|
|
PL377091A1
(pl)
|
2002-09-06 |
2006-01-23 |
Amgen, Inc. |
Ludzkie monoklonalne przeciwciało przeciw-IL-1R1, o właściwościach terapeutycznych
|
|
US7335743B2
(en)
|
2002-10-16 |
2008-02-26 |
Amgen Inc. |
Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
|
|
AU2003298816C1
(en)
|
2002-12-02 |
2010-12-16 |
Amgen Fremont, Inc. |
Antibodies directed to Tumor Necrosis Factor and uses thereof
|
|
EP2457587A1
(en)
|
2003-06-27 |
2012-05-30 |
Amgen Fremont Inc. |
Anitbodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
|
|
TWI385180B
(zh)
|
2003-07-15 |
2013-02-11 |
安美基公司 |
作為選擇性神經生長因子(ngf)通道抑制劑之人類抗-ngf中和抗體
|
|
EP1648935A2
(en)
|
2003-07-25 |
2006-04-26 |
Amgen Inc. |
Antagonists and agonists of ldcam and methods of use
|
|
HN2004000285A
(es)
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
|
US7318925B2
(en)
|
2003-08-08 |
2008-01-15 |
Amgen Fremont, Inc. |
Methods of use for antibodies against parathyroid hormone
|
|
DE60325906D1
(de)
|
2003-08-08 |
2009-03-05 |
Amgen Fremont Inc |
Antikörper gegen parath-hormon (pth) und ihre verwendungen
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
EP1692184B1
(en)
|
2003-11-07 |
2012-03-07 |
Immunex Corporation |
Antibodies that bind interleukin-4 receptor
|
|
WO2005058961A2
(en)
|
2003-12-12 |
2005-06-30 |
Amgen Inc. |
Antibodies specific for human galanin, and uses thereof
|
|
ES2362667T3
(es)
|
2004-01-09 |
2011-07-11 |
Pfizer Inc. |
ANTICUERPOS FRENTE A MAdCAM.
|
|
US7449555B2
(en)
|
2004-04-23 |
2008-11-11 |
Amgen Inc. |
Antibodies of angiogenesis inhibiting domains CD148
|
|
WO2005118643A2
(en)
|
2004-04-23 |
2005-12-15 |
Amgen Inc. |
Antibodies to angiogenesis inhibiting domains of cd148
|
|
MX2007001221A
(es)
|
2004-08-04 |
2007-03-23 |
Amgen Inc |
Anticuerpos para proteina dickkopf-1 (dkk-1).
|
|
US7423128B2
(en)
|
2004-11-03 |
2008-09-09 |
Amgen Fremont Inc. |
Anti-properdin antibodies, and methods for making and using same
|
|
JP2008520684A
(ja)
|
2004-11-17 |
2008-06-19 |
アブジェニックス・インコーポレーテッド |
Il−13に対する完全ヒトモノクローナル抗体
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
AU2006208226A1
(en)
|
2005-01-24 |
2006-08-03 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
|
WO2006081139A2
(en)
|
2005-01-26 |
2006-08-03 |
Abgenix, Inc. |
Antibodies against interleukin-1 beta
|
|
EP1868647A4
(en)
|
2005-03-24 |
2009-04-01 |
Millennium Pharm Inc |
OV064 BINDING ANTIBODIES AND METHOD FOR THEIR USE
|
|
EA015534B1
(ru)
|
2005-04-25 |
2011-08-30 |
Пфайзер Инк. |
Антитела к миостатину и способы их применения
|
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
|
EP2397497A3
(en)
|
2005-07-18 |
2013-11-27 |
Amgen, Inc |
Human anti-B7RP1 neutralizing antibodies
|
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
|
DOP2006000195A
(es)
|
2005-09-07 |
2017-08-15 |
Amgen Fremont Inc |
Anticuerpos monoclonales humanos para la quinasa-1 tipo receptor de activina
|
|
HRP20120421T1
(hr)
|
2005-12-13 |
2012-07-31 |
Medimmune@Limited |
Vezni proteini specifični za inzulinu slične čimbenike rasta i njihova upotreba
|
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
US7888482B2
(en)
|
2006-02-10 |
2011-02-15 |
Amgen Inc. |
Antibodies that bind PAR-2
|
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之c-kit抗體
|
|
EP2035454A2
(en)
|
2006-05-19 |
2009-03-18 |
Amgen, Inc. |
Antibodies to sars coronavirus
|
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
CL2007002668A1
(es)
|
2006-09-20 |
2008-05-09 |
Amgen Inc |
Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2.
|
|
US7833527B2
(en)
|
2006-10-02 |
2010-11-16 |
Amgen Inc. |
Methods of treating psoriasis using IL-17 Receptor A antibodies
|
|
SG182985A1
(en)
|
2007-04-02 |
2012-08-30 |
Amgen Fremont Inc |
Anti-ige antibodies
|
|
CL2008001887A1
(es)
|
2007-06-29 |
2008-10-03 |
Amgen Inc |
Proteinas de union a antigeno que se unen al receptor activado por proteasas 2 (par-2); acido nucleico que las codifica; vector y celula huesped; metodo de produccion; y composicion que las comprende.
|
|
WO2009009086A2
(en)
|
2007-07-12 |
2009-01-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut 8) gene expression
|
|
CL2008002153A1
(es)
|
2007-07-24 |
2009-06-05 |
Amgen Inc |
Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
|
|
EP2592093A1
(en)
|
2007-08-21 |
2013-05-15 |
Amgen, Inc |
Human c-fms antigen binding proteins
|
|
JOP20080381B1
(ar)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
|
US8414893B2
(en)
|
2007-12-21 |
2013-04-09 |
Amgen Inc. |
Anti-amyloid antibodies and uses thereof
|
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
|
ES2487846T3
(es)
|
2008-05-01 |
2014-08-25 |
Amgen, Inc. |
Anticuerpos anti-hepcindina y métodos de uso
|
|
TWI466681B
(zh)
|
2009-03-20 |
2015-01-01 |
Amgen Inc |
α4β7雜二聚體專一性拮抗抗體
|
|
KR101641526B1
(ko)
|
2009-06-02 |
2016-07-21 |
리제너론 파마슈티칼스 인코포레이티드 |
푸코실화-결핍 세포
|
|
CA2773240C
(en)
|
2009-09-22 |
2015-11-10 |
Volker Sandig |
Process for producing molecules containing specialized glycan structures
|
|
TR201804897T4
(tr)
|
2009-10-07 |
2018-06-21 |
Macrogenics Inc |
Fukosi̇lasyon ölçüsünün deği̇şi̇mleri̇nden dolayi geli̇şmi̇ş efektör i̇şlevi̇ sergi̇leyen fc bölgesi̇ni̇ i̇çeren poli̇pepti̇tler ve bunlarin kullanimlarina yöneli̇k yöntemler
|
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
|
RU2017122482A
(ru)
|
2010-08-05 |
2019-01-30 |
Сиэтл Дженетикс, Инк. |
Способы ингибирования фукозилирования белков in vivo с использованием аналогов фукозы
|
|
CN104220603B
(zh)
*
|
2012-02-10 |
2017-06-06 |
马里兰大学,巴尔的摩 |
抗体及其Fc片段的化学酶法糖基化工程
|
|
US20160237399A1
(en)
|
2015-02-18 |
2016-08-18 |
Biogen Ma Inc. |
Control of Protein Glycosylation by Culture Medium Supplementation and Cell Culture Process Parameters
|
|
TWI682033B
(zh)
|
2014-03-17 |
2020-01-11 |
泉盛生物科技股份有限公司 |
製造具有經修飾的糖苷化作用之重組糖蛋白之方法
|
|
CA2950577A1
(en)
*
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Fucosidase from bacteroides and methods using the same
|
|
EP3194583B1
(en)
|
2014-07-30 |
2021-09-15 |
Zumutor Biologics, Inc. |
Non-fucosylated protein and methods thereof
|
|
WO2016075662A2
(en)
|
2014-11-15 |
2016-05-19 |
Zumutor Biologics, Inc. |
Dna-binding domain, non-fucosylated and partially fucosylated proteins, and methods thereof
|
|
PL3227454T3
(pl)
|
2014-12-01 |
2020-07-27 |
Amgen Inc. |
Sposób manipulowania poziomem zawartości glikanów w glikoproteinie
|
|
JP6587696B2
(ja)
|
2015-05-13 |
2019-10-09 |
ズムトール バイオロジクス、インコーポレイテッド |
アフコシル化タンパク質、前記タンパク質を発現する細胞、及び関連する方法
|
|
EP3371206B1
(en)
|
2015-11-02 |
2021-04-14 |
F. Hoffmann-La Roche AG |
Methods of making fucosylated and afucosylated forms of a protein
|
|
CN109715819A
(zh)
|
2016-08-10 |
2019-05-03 |
马里兰大学帕克分校 |
设计者α1,6-岩藻糖苷酶突变体实现完整N-糖肽和N-糖蛋白的直接核心岩藻糖基化
|
|
TWI727884B
(zh)
|
2016-08-24 |
2021-05-11 |
醣基生醫股份有限公司 |
利用醣苷內切酶突變體重塑醣蛋白及其使用方法
|
|
EP3339444A1
(en)
|
2016-12-20 |
2018-06-27 |
Mabxience Research, S.L. |
Method for obtaining a glycoprotein with an increased percentage of afucosylated glycans
|
|
AU2018235928B2
(en)
|
2017-03-14 |
2023-09-21 |
Amgen Inc. |
Control of total afucosylated glycoforms of antibodies produced in cell culture
|
|
US10260056B2
(en)
*
|
2017-03-17 |
2019-04-16 |
New England Biolabs, Inc. |
Cleavage of fucose in N-glycans
|
|
CN107881160A
(zh)
|
2017-08-11 |
2018-04-06 |
百奥泰生物科技(广州)有限公司 |
一种由基因组被编辑的cho宿主细胞产生的具有独特糖谱的重组抗体及其制备方法
|
|
CA3093853A1
(en)
|
2018-03-26 |
2019-10-03 |
Amgen Inc. |
Total afucosylated glycoforms of antibodies produced in cell culture
|
|
CN110373374B
(zh)
|
2018-04-12 |
2023-07-07 |
上海颢哲信息科技有限公司 |
一种降低抗体核心岩藻糖基化的方法和组合物
|
|
AU2019274782A1
(en)
|
2018-05-24 |
2020-12-03 |
Ares Trading S.A. |
Method for controlling the afucosylation level of a glycoprotein composition
|
|
JP2021528074A
(ja)
|
2018-06-20 |
2021-10-21 |
マサチューセッツ インスティテュート オブ テクノロジー |
特徴的なグリカン構造を有するプロテオグリカンを糖鎖工学的に改変する方法
|
|
EP3833688A1
(en)
|
2018-08-10 |
2021-06-16 |
Genentech, Inc. |
Cell culture strategies for modulating protein glycosylation
|
|
CN113166728A
(zh)
|
2018-08-29 |
2021-07-23 |
联合生物制药股份有限公司 |
去岩藻醣基化抗体及其制造
|
|
BR112021003793A2
(pt)
|
2018-08-29 |
2021-05-18 |
United Biopharma Inc |
método para produzir uma proteína afucosilada em uma célula hospedeira
|
|
HU231514B1
(hu)
|
2018-11-07 |
2024-07-28 |
Richter Gedeon Nyrt. |
Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer
|
|
CN114026229B
(zh)
*
|
2019-08-05 |
2025-03-25 |
醣基生医股份有限公司 |
用于重塑抗体醣型之融合蛋白
|